Gsk Share Discussion Threads

[pj fozzie] 30/4/2018 21:42

Very odd, even the most casual observer of big pharma would have a double take at the "Forward yield 2.73%" statement for GSK. Not really a great advert for Seeking Alpha reporting quality is it. [ Nor a great advert for the expertise of derivative traders either ;-) ]

Cheers,
PJ

[jadeticl3] 30/4/2018 20:32

Come on Fangorn! Dividends are very important to users of this site, and are frequently discussed. Therefore your oversight is surprising, especially for one with your background. Let’s agree we all make gaffs and try to laugh them off.

[woodhawk] 30/4/2018 19:39

Of course you did ;-)

[sicker] 30/4/2018 18:10

ok fanghorn but I have yet to see anything in need of correction :-) This (annual)dividend has been unchanged for the last few years.

[woodhawk] 30/4/2018 18:06

If you believe everything you read on some random website - you deserve everything you get! Didn't you know the usual divi structure for GSK is 3 x 19p and one x 23p? Do you know what a forward yield is?

[sicker] 30/4/2018 17:36

Fangorn2, that is not a decrease in overall 80p dividend. 1st quarter 19p, 2nd quarter
19p, 3rd quarter 19p final 23p as has been for a while now. (since April 2014)

[tradermichael] 30/4/2018 11:46

Long term 1950p plus all the dividends ...... ;0)

[ny boy] 30/4/2018 10:49

Take the middle ground between the two then 1605p!

Ex divi again 10 May, reasons to be cheerful

5%+ annual yield!

[jrphoenixw2] 27/4/2018 17:09

@Tompion
Isn't it a hoot. I don't know if any of them are worth the time it takes to read their forecasts. Any broker with a financial interest in a company can usually be simply ignored. For example 'House Brokers', or brokers/banks who underwrite stock/debt issuance for the subject company. Look at how few *dare* to issue sell ratings to see how one sided the whole field is.

[jrphoenixw2] 27/4/2018 17:05

'BillionDollarBrain 16 Apr '18 - 16:01 - 17284 of 17410
Immupharma (IMM) Phase III Lupuzor results expected this week.
Possible $ multi-billion blockbuster could lead to a massive re-rating of the share price.'

IMM share price 16Apr18 = 147p, price now = 32p; -78%. 'A massive re-rating' indeed, ouch!

[tompion] 27/4/2018 15:35

Love the brokers - two today giving updates targets - Berenberg giving 1790p and Deutsche Bank giving 1420p!

[tradermichael] 27/4/2018 15:24

Yes, and just 2 weeks to the next xdiv ...... ;0)

[ny boy] 27/4/2018 12:36

Defensive qualities, attractive quarterly divis, a solid blue chip global player, strong management..whatR17;s not to like, investors quickly bought the 1400p level

[alphorn] 27/4/2018 10:15

Obviously not a Treasurer. IMO you always need a 'view' on forex. If you are a global group with diversified operations it is part of the forecasting process. If you are a private individual it is part of the evaluation process unless one only invests in domestics.

[romeike] 27/4/2018 09:56

Trying to predict fx movements is a mug's game but despite what the idiot Carney says I can't see BOE raising rates unless they are forced to - that should mean downward pressure on GBP vs USD from early May, hopefully removing the unwanted drag on GSK revenues.

[ny boy] 27/4/2018 09:41

As expected, investors looking forward not backwards, plenty going on at GSK to be excited about

[ny boy] 26/4/2018 21:17

I make the US close tonight 1444p, US markets recovering.

Expect 1440/1450p tomorrow

[tim 3] 26/4/2018 19:41

Yes if we can break the recent high we back in the uptrend.

Very positive the way it bounces back after what some saw as a less than glowing update.